NCT00826969View on ClinicalTrials.gov

Ciclesonide for the Treatment of Airway Hyperresponsiveness

PHASE4CompletedINTERVENTIONAL

Enrollment

64

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

July 31, 2010

Study Completion Date

October 31, 2011

Conditions

Asthma

Interventions

DRUG

Ciclesonide

320µg Ciclesonide versus Placebo

DRUG

Placebo

Placebo

Trial Locations (1)

4031

Nycomed, Basel

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY